Celemics (331920.KQ) Stock Price

Celemics Price

CLOSED
8,240.00
​
Market closed

Over the last 8 years Celemics grew revenue by 13.7% annually, reaching 5.77 B KRW. For Celemics, the net margin of -70.0% is down versus -64.8% a few years ago.

Celemics stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celemics business model & stock analysis

Celemics Inc is a South Korean company based in Seoul, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company provides biotechnology services, focusing on the development and sale of target capture kit products. It also offers immune repertoire analysis solutions and next-generation sequencing solutions. Celemics Inc went public through an IPO on August 21, 2020, and currently employs 63 full-time staff. The company's products are sold in both domestic and international markets. Its headquarters are located in Seoul, South Korea, and it maintains a website at www.celemics.com. The firm's primary business activities include the provision of specialized biotechnology services, with an emphasis on innovative tools and solutions for life science research and applications. Celemics Inc has a presence in the Korean market and extends its reach to global customers, supporting various research and diagnostic needs through its technology-driven services. The company's operational focus remains on developing and delivering advanced biotechnology solutions to meet the evolving demands of the life sciences industry.

Frequently asked questions about Celemics

5 analysts currently rate the Celemics stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Celemics share trades at 5.45 EUR (8,240.00 KRW).

The revenue cannot currently be calculated for Celemics.

The profit cannot currently be calculated for Celemics.

The P/E ratio cannot be calculated for Celemics at the moment.

The P/S cannot be calculated for Celemics currently.

The Eulerpool Quality Score for Celemics is 2/10.

The ISIN of Celemics is KR7331920009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Celemics is 331920.KQ. The ticker symbol is used to trade Celemics shares on the stock exchange.

Fair ValueTerminal
7,828.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
91.55 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website celemics.com
Country
South Korea
Currency
KRW
Initial public offering
Aug 21, 2020
ISIN
KR7331920009
Cusip
Y1R42J100
Market capitalization
67.68 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.94
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-17.54 %
Last updated Nov 6, 2026, 3:39 AM

Celemics Peer Group

Celemics FIGI

331920:KS · BBG00VPKJQF5331920:KQ · BBG00VPKJQH3

All fundamentals and in-depth analysis of Celemics

Our stock analysis for Celemics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Celemics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.